Difference between revisions of "DANA-FARBER CANCER INSTITUTE, INC. patent applications published on March 21st, 2024"
Jump to navigation
Jump to search
Wikipatents (talk | contribs) |
Wikipatents (talk | contribs) (Creating a new page) |
||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
==Patent applications for DANA-FARBER CANCER INSTITUTE, INC. on March 21st, 2024== | ==Patent applications for DANA-FARBER CANCER INSTITUTE, INC. on March 21st, 2024== | ||
Revision as of 08:29, 27 March 2024
Contents
- 1 Patent applications for DANA-FARBER CANCER INSTITUTE, INC. on March 21st, 2024
- 1.1 COMPOUNDS FOR TAU PROTEIN DEGRADATION (18200950)
- 1.2 GENERATION OF ANTI-TUMOR T CELLS (18224865)
- 1.3 COMPOUNDS AND METHODS FOR TREATING CANCER (18503556)
- 1.4 METHODS FOR SENSITIZING CANCER CELLS TO T CELL-MEDIATED KILLING BY MODULATING MOLECULAR PATHWAYS (18234229)
- 1.5 C-RAF Mutants that Confer Resistance to RAF Inhibitors (18464360)
- 1.6 MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors (18461820)
Patent applications for DANA-FARBER CANCER INSTITUTE, INC. on March 21st, 2024
COMPOUNDS FOR TAU PROTEIN DEGRADATION (18200950)
Main Inventor
Nathanael S. Gray
GENERATION OF ANTI-TUMOR T CELLS (18224865)
Main Inventor
Catherine J. Wu
COMPOUNDS AND METHODS FOR TREATING CANCER (18503556)
Main Inventor
James Bradner
METHODS FOR SENSITIZING CANCER CELLS TO T CELL-MEDIATED KILLING BY MODULATING MOLECULAR PATHWAYS (18234229)
Main Inventor
Deng Pan
C-RAF Mutants that Confer Resistance to RAF Inhibitors (18464360)
Main Inventor
Caroline Emery
MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors (18461820)
Main Inventor
Levi A. Garraway
